The Prevalence and Incidence of Dementia Due to Alzheimer's Disease: a Systematic Review and Meta-Analysis
- PMID: 27307128
- DOI: 10.1017/cjn.2016.36
The Prevalence and Incidence of Dementia Due to Alzheimer's Disease: a Systematic Review and Meta-Analysis
Abstract
Background: Updated information on the epidemiology of dementia due to Alzheimer's disease (AD) is needed to ensure that adequate resources are available to meet current and future healthcare needs. We conducted a systematic review and meta-analysis of the incidence and prevalence of AD.
Methods: The MEDLINE and EMBASE databases were searched from 1985 to 2012, as well as the reference lists of selected articles. Included articles had to provide an original population-based estimate for the incidence and/or prevalence of AD. Two individuals independently performed abstract and full-text reviews, data extraction and quality assessments. Random-effects models were employed to generate pooled estimates stratified by age, sex, diagnostic criteria, location (i.e., continent) and time (i.e., when the study was done).
Results: Of 16,066 abstracts screened, 707 articles were selected for full-text review. A total of 119 studies met the inclusion criteria. In community settings, the overall point prevalence of dementia due to AD among individuals 60+ was 40.2 per 1000 persons (CI95%: 29.1-55.6), and pooled annual period prevalence was 30.4 per 1000 persons (CI95%: 15.6-59.1). In community settings, the overall pooled annual incidence proportion of dementia due to AD among individuals 60+ was 34.1 per 1000 persons (CI95%: 16.4-70.9), and the incidence rate was 15.8 per 1000 person-years (CI95%: 12.9-19.4). Estimates varied significantly with age, diagnostic criteria used and location (i.e., continent).
Conclusions: The burden of AD dementia is substantial. Significant gaps in our understanding of its epidemiology were identified, even in a high-income country such as Canada. Future studies should assess the impact of using such newer clinical diagnostic criteria for AD dementia such as those of the National Institute on Aging-Alzheimer's Association and/or incorporate validated biomarkers to confirm the presence of Alzheimer pathology to produce more precise estimates of the global burden of AD.
Keywords: Alzheimer’s; dementia; meta-analysis; systematic review.
Similar articles
-
The Prevalence and Incidence of Dementia: a Systematic Review and Meta-analysis.Can J Neurol Sci. 2016 Apr;43 Suppl 1:S3-S50. doi: 10.1017/cjn.2016.18. Can J Neurol Sci. 2016. PMID: 27307127
-
Donepezil for dementia due to Alzheimer's disease.Cochrane Database Syst Rev. 2018 Jun 18;6(6):CD001190. doi: 10.1002/14651858.CD001190.pub3. Cochrane Database Syst Rev. 2018. PMID: 29923184 Free PMC article.
-
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2. Cochrane Database Syst Rev. 2017. PMID: 28328043 Free PMC article.
-
Pharmacotherapies for sleep disturbances in dementia.Cochrane Database Syst Rev. 2016 Nov 16;11(11):CD009178. doi: 10.1002/14651858.CD009178.pub3. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2020 Nov 15;11:CD009178. doi: 10.1002/14651858.CD009178.pub4. PMID: 27851868 Free PMC article. Updated.
-
18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012216. doi: 10.1002/14651858.CD012216.pub2. Cochrane Database Syst Rev. 2017. PMID: 29164603 Free PMC article.
Cited by
-
Is heart disease a risk factor for low dementia test battery scores in older persons with Down syndrome? Exploratory, pilot study, and commentary.Int J Dev Disabil. 2020;66(1):22-35. doi: 10.1080/20473869.2017.1301023. Epub 2017 Apr 9. Int J Dev Disabil. 2020. PMID: 33859818 Free PMC article.
-
Naturally Occurring Acetylcholinesterase Inhibitors and Their Potential Use for Alzheimer's Disease Therapy.Front Pharmacol. 2018 Oct 18;9:1192. doi: 10.3389/fphar.2018.01192. eCollection 2018. Front Pharmacol. 2018. PMID: 30405413 Free PMC article. Review.
-
Sex differences and modifiable dementia risk factors synergistically influence memory over the adult lifespan.Alzheimers Dement (Amst). 2022 Apr 1;14(1):e12301. doi: 10.1002/dad2.12301. eCollection 2022. Alzheimers Dement (Amst). 2022. PMID: 35386471 Free PMC article.
-
Secular trends in the prevalence of dementia based on a community-based complete enumeration in Japan: the Nakayama Study.Psychogeriatrics. 2022 Sep;22(5):631-641. doi: 10.1111/psyg.12865. Epub 2022 Jun 26. Psychogeriatrics. 2022. PMID: 35753054 Free PMC article.
-
The Comparative Efficacy of Multiple Acupuncture for Alzheimer's Disease: A Bayesian Network Meta-Analysis.Evid Based Complement Alternat Med. 2022 May 17;2022:3288948. doi: 10.1155/2022/3288948. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35620408 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous